Unknown

Dataset Information

0

MiR-29b as a therapeutic agent for angiotensin II-induced cardiac fibrosis by targeting TGF-?/Smad3 signaling.


ABSTRACT: Loss of miR-29 is associated with cardiac fibrosis. This study examined the role and therapeutic potential of miR-29 in mouse model of hypertension induced by angiotensin II (AngII). By using microRNA microarray, in situ hybridization, and real-time polymerase chain reaction, we found that AngII-induced cardiac fibrosis in the hypertensive heart and in cultured cardiac fibroblasts were associated with downregulation of miR-29a-c via a Smad3-dependent mechanism. In vitro knockdown of miR-29b enhanced but overexpression of miR-29b inhibited AngII-induced fibrosis, revealing a protective role of miR-29b in cardiac fibrosis in response to AngII. This was further demonstrated in vivo by the ability of overexpressing miR-29b in the mouse heart to prevent AngII-mediated cardiac fibrosis and cardiac dysfunction. Importantly, we also found that restored miR-29b in the established hypertensive heart was capable of blocking progressive cardiac fibrosis and improving cardiac dysfunction, demonstrating a therapeutic potential of miR-29b for chronic heart disease. Further studies revealed that targeting the transforming growth factor (TGF)-?1 coding sequence region, thereby inhibiting TGF-?/Smad3 signaling, could be a new mechanism by which miR-29b inhibited AngII-induced cardiac fibrosis. In conclusion, miR-29b plays a protective role in AngII-mediated cardiac remodeling and may be a therapeutic agent for cardiac fibrosis by targeting the TGF-?/Smad3 pathway.

SUBMITTER: Zhang Y 

PROVIDER: S-EPMC4015231 | biostudies-literature | 2014 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

miR-29b as a therapeutic agent for angiotensin II-induced cardiac fibrosis by targeting TGF-β/Smad3 signaling.

Zhang Yang Y   Huang Xiao-Ru XR   Wei Li-Hua LH   Chung Arthur Ck AC   Yu Cheuk-Man CM   Lan Hui-Yao HY  

Molecular therapy : the journal of the American Society of Gene Therapy 20140226 5


Loss of miR-29 is associated with cardiac fibrosis. This study examined the role and therapeutic potential of miR-29 in mouse model of hypertension induced by angiotensin II (AngII). By using microRNA microarray, in situ hybridization, and real-time polymerase chain reaction, we found that AngII-induced cardiac fibrosis in the hypertensive heart and in cultured cardiac fibroblasts were associated with downregulation of miR-29a-c via a Smad3-dependent mechanism. In vitro knockdown of miR-29b enha  ...[more]

Similar Datasets

| S-EPMC8375072 | biostudies-literature
| S-EPMC4414609 | biostudies-literature
| S-EPMC6963096 | biostudies-literature
| S-EPMC7494905 | biostudies-literature
| S-EPMC7868689 | biostudies-literature
| S-EPMC3344835 | biostudies-literature
| S-EPMC9357610 | biostudies-literature
| S-EPMC3744547 | biostudies-other
| S-EPMC4520156 | biostudies-literature
| S-EPMC5487499 | biostudies-literature